I don't like pubs http://highhalstow.org.uk/stmap_39bocxge.html?copegus.viagra.lincocin cost levothyroxine For example, Valeant Pharmaceuticals, the lastlarge M&A issuer to tap the high-yield market, nearly approachedits cap rate. The USD1.625bn eight-year non-call three seniorunsecured notes tranche, part of the financing for Valeant'spurchase of Bausch and Lomb, priced in late June at 7.5%. Thiswas heard to have been around just 25bp under its cap in thehigh 7% range.